Unknown

Dataset Information

0

Polydatin improves osteogenic differentiation of human bone mesenchymal stem cells by stimulating TAZ expression via BMP2-Wnt/?-catenin signaling pathway.


ABSTRACT: OBJECTIVES:Polydatin (PD), extracted from Polygonum cuspidatum, has shown potential therapeutic applications due to its antiosteoporotic and anti-inflammatory activities. Our previous study suggested that PD promotes the osteogenesis of human bone marrow stromal cells (hBMSCs) via the BMP2-Wnt/?-catenin pathway. The aim of our present study was to further explore the role of PD-mediated regulation of Tafazzin (TAZ), a transcriptional coactivator with a PDZ-binding motif, in osteogenesis. MATERIALS AND METHODS:hBMSCs were isolated and treated with PD at various concentrations. Alizarin red staining and RT-qPCR were performed to identify calcium complex deposition in hBMSCs as well as the expression of specific osteoblast-related markers, respectively, in each group. Next, TAZ-silenced hBMSCs were generated by lentivirus-produced TAZ shRNA. After treatment with PD, the osteogenic abilities of the TAZ-silenced and control hBMSCs were estimated by ALP activity assay, and expression of the TAZ protein was detected by Western blot analysis and immunofluorescence staining. In vitro, an ovariectomized (OVX) mouse model was established and used to evaluate the effect of PD on bone destruction by micro-CT, immunohistochemistry, and ELISA. RESULTS:In vitro, 30??M PD significantly improved the proliferation and calcium deposition of hBMSCs and markedly stimulated the expression of the mRNAs RUNX2, Osteopontin, DLX5, ?-catenin, TAZ, and Osteocalcin (OCN). Osteogenic differentiation induced by PD was blocked by lentivirus-mediated TAZ shRNA. Furthermore, Noggin (a regulator of bone morphogenic protein 2 (BMP2)) and DKK1 (an inhibitor of the Wnt/?-catenin pathway) were found to inhibit the increase in TAZ expression induced by PD. In vivo, PD prevented estrogen deficiency-induced bone loss in the OVX mouse model. CONCLUSION:Taken together, our findings suggest that PD improved the osteogenic differentiation of hBMSCs and maintained the bone matrix in the OVX mouse model through the activation of TAZ, a potential target gene of the BMP2-Wnt/?-catenin pathway.

SUBMITTER: Shen YS 

PROVIDER: S-EPMC7251742 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Polydatin improves osteogenic differentiation of human bone mesenchymal stem cells by stimulating TAZ expression via BMP2-Wnt/β-catenin signaling pathway.

Shen Ying-Shan YS   Chen Xiao-Jun XJ   Wuri Sha-Na SN   Yang Fan F   Pang Feng-Xiang FX   Xu Liang-Liang LL   He Wei W   Wei Qiu-Shi QS  

Stem cell research & therapy 20200527 1


<h4>Objectives</h4>Polydatin (PD), extracted from Polygonum cuspidatum, has shown potential therapeutic applications due to its antiosteoporotic and anti-inflammatory activities. Our previous study suggested that PD promotes the osteogenesis of human bone marrow stromal cells (hBMSCs) via the BMP2-Wnt/β-catenin pathway. The aim of our present study was to further explore the role of PD-mediated regulation of Tafazzin (TAZ), a transcriptional coactivator with a PDZ-binding motif, in osteogenesis.  ...[more]

Similar Datasets

| S-EPMC8183571 | biostudies-literature
| S-EPMC6341609 | biostudies-literature
| S-EPMC10599756 | biostudies-literature
| S-EPMC6593611 | biostudies-literature
| S-EPMC5264139 | biostudies-literature
| S-EPMC3865600 | biostudies-literature
| S-EPMC8515698 | biostudies-literature
| S-EPMC4013522 | biostudies-literature
| S-EPMC4899801 | biostudies-literature
| S-EPMC6358999 | biostudies-literature